Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Sarepta Therapeutics (NQ: SRPT ) 113.33 -10.13 (-8.21%) Streaming Delayed Price Updated: 4:00 PM EDT, May 28, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 3,047,549 Open 119.02 Bid (Size) 113.40 (1) Ask (Size) 117.50 (1) Prev. Close 123.46 Today's Range 109.91 - 120.00 52wk Range 55.25 - 146.68 Shares Outstanding 93,148,652 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Sarepta Downgraded As FDA Decision Date Approaches, Shares Up 50% Over Last Six Months May 28, 2024 RBC Capital Markets downgrades Sarepta Therapeutics following increased FDA label expansion expectations for Elevidys and recent stock surge. Via Benzinga Exposures Product Safety Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 28, 2024 Via Benzinga Performance YTD +17.79% +17.79% 1 Month -8.79% -8.79% 3 Month -16.99% -16.99% 6 Month +36.76% +36.76% 1 Year -13.89% -13.89% More News Read More 10 Health Care Stocks With Whale Alerts In Today's Session May 24, 2024 Via Benzinga 12 Analysts Have This To Say About Sarepta Therapeutics May 20, 2024 Via Benzinga What Analysts Are Saying About Sarepta Therapeutics Stock May 02, 2024 Via Benzinga The 2030 Millionaire’s Club: 3 Biotech Stocks to Buy Now May 23, 2024 Via InvestorPlace Jim Cramer: This Industrial Stock Is Doing 'Very Well'; Here's His Take On Palantir May 22, 2024 Via Benzinga Why Dyne Therapeutics, With A 108% Run This Year, Just Catapulted Again May 20, 2024 Via Investor's Business Daily 3 Biotech Stocks With the Potential to Make You an Overnight Millionaire May 04, 2024 Via InvestorPlace Exposures Product Safety Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health May 03, 2024 From Sarepta Therapeutics, Inc. Via Business Wire Apple, Kellanova And 3 Stocks To Watch Heading Into Thursday May 02, 2024 Via Benzinga SRPT Stock Earnings: Sarepta Therapeutics Beats EPS, Beats Revenue for Q1 2024 May 01, 2024 Via InvestorPlace Sarepta Therapeutics (SRPT) Q1 2024 Earnings Call Transcript May 01, 2024 Via The Motley Fool Topics Earnings Exposures Financial Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments May 01, 2024 From Sarepta Therapeutics, Inc. Via Business Wire 1 Top Growth Stock to Buy and Hold for 10 Years May 01, 2024 Via The Motley Fool Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 30, 2024 From Sarepta Therapeutics, Inc. Via Business Wire Sarepta Therapeutics Stock Shows Improved Technical Strength April 29, 2024 Via Investor's Business Daily Sarepta Therapeutics to Announce First Quarter 2024 Financial Results April 24, 2024 From Sarepta Therapeutics, Inc. Via Business Wire Why Sarepta's First-Quarter Report Is Already Dead In The Water: Analyst April 08, 2024 Via Investor's Business Daily 2 Biotech Stocks to Buy Hand Over Fist in April April 06, 2024 Via The Motley Fool 10 Health Care Stocks Whale Activity In Today's Session April 04, 2024 Via Benzinga Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 29, 2024 From Sarepta Therapeutics, Inc. Via Business Wire How Sleeper Biotech Solid Biosciences, With A 687% Gain, Is Making A Comeback March 28, 2024 Via Investor's Business Daily Does This 1 New Threat Make Sarepta Therapeutics Stock Worth Selling? March 13, 2024 Via The Motley Fool This Gene Therapy Player Duchenne Data Is Impressive, Analyst Upgrades REGENXBIO March 08, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
